Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read ...

Thousands of bottles of a popular combination drug used to treat high blood pressure have been recalled across the United ...

The data we're presenting at CTAD highlights two critical aspects of successful Alzheimer's drug development,” said Jim Doherty, PhD, President and Chief Development Officer of Acumen Pharmaceuticals.

In a world where gadgets are king and the tech landscape is a wild frontier, finding the ultimate gift can feel like navigating through a maze of endless choices. That's where we come in. We've ...